Caldesmon Protein (Transcript Variant 3) (Myc-DYKDDDDK Tag)
Quick Overview for Caldesmon Protein (Transcript Variant 3) (Myc-DYKDDDDK Tag) (ABIN2713048)
Target
See all Caldesmon (CALD1) ProteinsProtein Type
Origin
Source
Application
Purity
-
-
Protein Characteristics
- Transcript Variant 3
-
Purification tag / Conjugate
- This Caldesmon protein is labelled with Myc-DYKDDDDK Tag.
-
Characteristics
-
- Recombinant human Caldesmon (transcript variant 3) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Comment
-
The tag is located at the C-terminal.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 50 μg/mL
-
Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- Caldesmon (CALD1) (Caldesmon 1 (CALD1))
-
Alternative Name
- Caldesmon
-
Background
- This gene encodes a calmodulin- and actin-binding protein that plays an essential role in the regulation of smooth muscle and nonmuscle contraction. The conserved domain of this protein possesses the binding activities to Ca(2+)-calmodulin, actin, tropomyosin, myosin, and phospholipids. This protein is a potent inhibitor of the actin-tropomyosin activated myosin MgATPase, and serves as a mediating factor for Ca(2+)-dependent inhibition of smooth muscle contraction. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms.
-
Molecular Weight
- 65.4 kDa
-
NCBI Accession
- NP_149347
-
Pathways
- Myometrial Relaxation and Contraction
Target
-